HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
RDNT
Radnet Inc
Healthcare Diagnostics & Research · California, USA · Reports in usd
Market Cap: $4.07B
Market Cap
$4.07B
Enterprise Val
$5.55B
P/E Ratio
-286.51
P/B Ratio
3.76
Trailing PEG (1Y)
18.26
As Of
May 14, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value$1.35B
Gross Margin4.36%
Profit Margin4.36%
Return on Equity-1.36%
Return on Assets-0.38%
Current Ratio1.17
Debt/Equity1.79
LT Debt/Equity1.70
Revenue Per Share7.42

Income Statement

Mar 31, 2026
Revenue$575.6M
Cost of Revenue$550.5M
Gross Profit$25.1M
R&D$0.00
SG&A$0.00
Operating Expenses$49.0M
Operating Income-$23.9M
Interest Expense$17.7M
Tax Expense-$8.1M
Net Income-$33.5M
EPS (Basic)$-0.43
EPS (Diluted)$-0.43
EBIT-$23.9M
EBITDA$37.4M
Consolidated Income-$24.7M
Non-Controlling Interests$8.7M

Balance Sheet

Mar 31, 2026
Cash & Equivalents$455.3M
Accounts Receivable$220.1M
Inventory$0.00
Current Assets$740.8M
LT Investments$131.4M
Property, Plant & Equipment$1.62B
Intangibles$1.35B
Non-Current Assets$3.14B
Total Assets$3.89B
Accounts Payable$530.6M
Current Debt$93.1M
Current Liabilities$635.6M
LT Debt$1.84B
Non-Current Liabilities$1.90B
Total Liabilities$2.53B
Total Debt$1.93B
Retained Earnings-$128.9M
Shareholder Equity$1.08B
Shares Outstanding77,612,125

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow$79.0M
Investing Cash Flow-$371.0M
Financing Cash Flow-$17.5M
CapEx-$69.7M
Free Cash Flow$9.3M
Depreciation & Amort.$61.3M
Stock-Based Comp$31.4M
Acquisitions / Disposals-$304.2M
Investment Activity$2.8M
Debt Issued/Repaid-$15.2M
Equity Issued/Repaid$103.0K
Dividends Paid$0.00
Net Change in Cash-$311.9M
Data cached · Meta live · Daily live · Statements live · TTL 24h